HER2 Support Group Forums - Addition Of Everolimus To Exemestine Provides Sustained Survival Edge In Women With A

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - Addition Of Everolimus To Exemestine Provides Sustained Survival Edge In Women With A (https://her2support.org/vbulletin/showthread.php?t=56804)

News	12-11-2012 03:20 PM

Addition Of Everolimus To Exemestine Provides Sustained Survival Edge In Women With A

SAN ANTONIO - The survival benefit seen with everolimus plus exemestane over exemestane alone at 7.5 months and 12.5 months in women with advanced breast cancer is maintained at 18- month follow-up, investigators announced at the San Antonio Breast Cancer Symposium (SABCS)...

More...

All times are GMT -7. The time now is 12:44 AM.